You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 14, 2024

Primus Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for PRIMUS PHARMS, and what generic alternatives to PRIMUS PHARMS drugs are available?

PRIMUS PHARMS has three approved drugs.

There are twelve US patents protecting PRIMUS PHARMS drugs.

There are thirty-one patent family members on PRIMUS PHARMS drugs in sixteen countries.

Summary for Primus Pharms
International Patents:31
US Patents:12
Tradenames:3
Ingredients:3
NDAs:3

Drugs and US Patents for Primus Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Primus Pharms IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes 9,956,231 ⤷  Sign Up Y ⤷  Sign Up
Primus Pharms SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079-001 Feb 5, 2016 RX Yes Yes 9,775,851 ⤷  Sign Up Y ⤷  Sign Up
Primus Pharms SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079-001 Feb 5, 2016 RX Yes Yes 9,655,907 ⤷  Sign Up Y ⤷  Sign Up
Primus Pharms SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079-001 Feb 5, 2016 RX Yes Yes 9,433,630 ⤷  Sign Up Y ⤷  Sign Up
Primus Pharms SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079-001 Feb 5, 2016 RX Yes Yes 9,364,485 ⤷  Sign Up Y ⤷  Sign Up
Primus Pharms IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes 9,855,334 ⤷  Sign Up Y ⤷  Sign Up
Primus Pharms IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes 10,588,914 ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for PRIMUS PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Spray 0.05% ➤ Subscribe 2018-02-15

International Patents for Primus Pharms Drugs

Country Patent Number Estimated Expiration
New Zealand 735341 ⤷  Sign Up
Russian Federation 2017134440 ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2020263768 ⤷  Sign Up
Japan 2021008505 ⤷  Sign Up
Spain 2861374 ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2011026076 ⤷  Sign Up
South Korea 20200051854 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.